Insulin price hike hits ₦25,000: Doctors warn of crisis

The insulin price hike in Nigeria has sent shockwaves through the healthcare sector, with the cost of life-saving medication jumping from ₦5,000 to ₦25,000 in recent months. This staggering increase has left millions of diabetes patients struggling to afford their daily doses, prompting doctors across the country to raise the alarm and call for urgent government intervention.

Diabetes is a growing public health challenge in Nigeria, with over 2 million diagnosed cases and many more undiagnosed. The sudden spike in insulin prices threatens to reverse years of progress in managing this chronic condition, placing an unbearable financial burden on families already grappling with economic hardship.

In this report, we examine the causes behind the insulin price hike, its devastating impact on patients, and what health experts say must be done to avert a full-blown healthcare crisis.

Why Nigeria’s insulin price hike is a national emergency

The insulin price hike from ₦5,000 to ₦25,000 is not just a market fluctuation—it is a national emergency with far-reaching consequences. Diabetes requires lifelong management, and insulin is the cornerstone of treatment for type 1 and many type 2 diabetes patients. When the cost of this essential drug becomes prohibitive, patients are forced to make impossible choices: pay for insulin or buy food, pay for insulin or pay school fees, or simply go without.

According to medical professionals, skipping or rationing insulin can lead to life-threatening complications such as ketoacidosis, nerve damage, kidney failure, and blindness. The Nigerian Association of Endocrinology and Metabolism (NAEM) has described the situation as a “ticking time bomb” that could overwhelm the healthcare system with preventable emergencies.

For many low-income families, the new price of ₦25,000 per vial is simply unaffordable. A typical diabetes patient may require two to four vials per month, pushing annual insulin costs to between ₦600,000 and ₦1.2 million—an amount far beyond the reach of most Nigerian households.

This crisis is not limited to Nigeria alone. Across Africa, rising drug prices are straining healthcare systems already under pressure from limited infrastructure and high disease burdens. The insulin price hike reflects broader challenges in access to essential medicines on the continent.

Global supply chain disruptions fuel price surge

Several factors have contributed to the insulin price hike in Nigeria. Global supply chain disruptions, including those caused by the COVID-19 pandemic, have led to shortages and increased transportation costs. Many insulin brands imported into Nigeria rely on raw materials sourced from Europe and North America, where production costs have risen.

The depreciation of the Nigerian naira against major currencies has also made imports more expensive. When the cost of bringing insulin into the country rises, retailers pass those costs on to consumers. Additionally, middlemen in the supply chain—wholesalers and distributors—often inflate prices before they reach pharmacies, compounding the burden on patients.

Local pharmaceutical manufacturers, though increasing production, cannot yet meet the full demand for insulin, especially for specialized types. This supply-demand imbalance further drives up prices in the open market.

Lack of local production worsens dependency

Nigeria currently imports over 70% of its pharmaceutical needs, including insulin. While efforts are underway to boost local production through initiatives like the National Drug Policy and the Nigeria Industrial Revolution Plan, the country still lacks full-scale insulin manufacturing capacity.

This heavy reliance on imports makes Nigeria vulnerable to global price shocks. Without domestic production, the country cannot shield its citizens from international price fluctuations. Experts argue that investing in local insulin production is not just a health policy—it is an economic and national security imperative.

How the insulin price hike is affecting Nigerian families

The human cost of the insulin price hike is already visible in clinics and communities across Nigeria. Patients who once managed their diabetes with routine medication are now skipping doses, visiting hospitals in crisis, or turning to unregulated alternatives.

Mrs. Amina Yusuf, a 45-year-old mother of three in Kano, shared her story: “Before, I spent ₦10,000 monthly on insulin. Now, it’s ₦50,000. I’ve had to reduce my dose to save money. Last week, I collapsed at home. My blood sugar was dangerously high.”

Like Amina, many patients are forced to ration insulin, using less than prescribed to make their supply last longer. This practice, known as “insulin underuse,” can lead to severe hyperglycemia, long-term organ damage, and even death.

In Lagos, diabetes support groups report an increase in emergency hospital admissions for complications linked to skipped insulin doses. Doctors at Lagos University Teaching Hospital (LUTH) have noted a 30% rise in diabetes-related crises since the price increase.

For families with children who have type 1 diabetes, the situation is especially dire. These children require multiple daily insulin injections, and missing even one dose can be fatal. Parents are now faced with impossible decisions: buy insulin or pay rent, buy insulin or send their child to school.

Doctors demand government action on insulin price hike

Medical professionals across Nigeria have united in calling for immediate government intervention to address the insulin price hike. The Nigerian Medical Association (NMA) and the Diabetes Association of Nigeria (DAN) have issued joint statements urging the federal government to declare insulin a “protected essential medicine” and implement price controls.

Key demands include:

• Subsidizing the cost of insulin to make it affordable for low-income patients
• Expanding the National Health Insurance Scheme (NHIS) to cover diabetes medications
• Increasing funding for local insulin production and research
• Strengthening regulatory oversight to prevent price gouging by distributors
• Introducing import duty waivers on insulin and related medical supplies

Dr. Akin Osibogun, a consultant endocrinologist in Abuja, emphasized the urgency: “This is not a time for policy documents. Lives are at stake. We need immediate price regulation and subsidies to prevent a diabetes epidemic from spiraling out of control.”

Calls for price regulation and subsidies

Price regulation has proven effective in other countries. In India, for example, the government capped the retail price of insulin at ₹275 (about ₦1,500) per vial, making it accessible to millions. South Africa’s Essential Drugs List includes insulin under its chronic medication benefit, reducing out-of-pocket costs for patients.

Nigeria’s Federal Ministry of Health has acknowledged the crisis and stated it is reviewing options to stabilize insulin prices. However, civil society groups argue that more must be done—faster.

Subsidies can be targeted to the most vulnerable groups, such as children with type 1 diabetes, pregnant women with gestational diabetes, and elderly patients with limited income. Digital health platforms like the NHIS e-claims system could be leveraged to ensure subsidies reach patients promptly.

Strengthening local production through incentives

To reduce reliance on imports, the government is being urged to offer tax incentives, grants, and low-interest loans to pharmaceutical companies willing to invest in insulin production. The National Agency for Food and Drug Administration and Control (NAFDAC) is also working to fast-track approvals for new local insulin manufacturers.

Local production would not only lower prices but also create jobs and improve Nigeria’s health security. Countries like Egypt and Morocco have made significant strides in local insulin manufacturing, setting a model for Nigeria to follow.

What can patients do amid the insulin price hike?

While waiting for government action, patients and caregivers can take steps to manage the impact of the insulin price hike:

• Join a support group: Organizations like the Diabetes Association of Nigeria offer guidance, shared resources, and advocacy. Connecting with others in similar situations can provide emotional and practical support.
• Explore generic alternatives: Some pharmacies offer generic insulin brands at lower costs. Ask your doctor if a generic version is suitable for your treatment plan.
• Use insulin safely and efficiently: Learn proper storage and injection techniques to avoid waste. Rotate injection sites to prevent lipohypertrophy, which can reduce insulin absorption.
• Apply for health insurance: If eligible, enroll in the NHIS or a state-level health insurance scheme that covers diabetes care.
• Seek financial assistance: Some NGOs and faith-based organizations provide grants or low-interest loans for diabetes patients. Inquire at your local hospital or community center.

Patients are also advised to avoid purchasing insulin from unlicensed vendors or online platforms with unverified sources, as counterfeit or expired insulin poses serious health risks.

How African countries are responding to rising insulin costs

The insulin price hike is not unique to Nigeria. Across Africa, rising drug costs are straining health systems and threatening progress in managing non-communicable diseases (NCDs). Several countries are taking proactive steps:

South Africa leads with price controls and NHI

South Africa has implemented price controls on essential medicines, including insulin, through its Medicine Pricing Committee. The country is also piloting the National Health Insurance (NHI) scheme, which aims to provide universal access to quality healthcare, including chronic medication.

Under the NHI, insulin is covered for eligible patients, reducing out-of-pocket expenses. This model is being watched closely by other African nations as a potential blueprint for equitable healthcare.

Kenya expands access through public-private partnerships

Kenya has partnered with international organizations to import affordable insulin and distribute it through public health facilities. The government also subsidizes insulin for vulnerable populations and is investing in local production capacity.

In 2023, Kenya launched the Universal Health Coverage (UHC) pilot program in four counties, including diabetes care. Early results show improved medication adherence among patients.

Ghana introduces insulin subsidies and tax breaks

Ghana has introduced a 20% subsidy on insulin for patients enrolled in the National Health Insurance Scheme (NHIS). The government has also waived import duties on insulin and related medical supplies to lower costs.

Additionally, Ghana is supporting local pharmaceutical companies to begin insulin production, with the first locally produced insulin expected by 2026.

What the future holds for insulin access in Nigeria

The path forward for Nigeria involves a combination of short-term relief and long-term structural change. In the immediate term, the government must act to stabilize insulin prices and protect patients. In the long term, investment in local production, health infrastructure, and universal coverage will be key.

The Federal Ministry of Health has indicated it is exploring a multi-pronged approach: price regulation, subsidies, and increased local manufacturing. Civil society organizations are pushing for transparency in pricing and stronger enforcement against price gouging.

Public awareness campaigns are also needed to educate patients on managing diabetes safely during the crisis and accessing available support.

Ultimately, the insulin price hike is a symptom of deeper systemic issues—weak health financing, over-reliance on imports, and inadequate regulation. Solving it will require political will, sustained funding, and collaboration between government, private sector, and civil society.

How to advocate for insulin price regulation in Nigeria

Patients and caregivers can play a role in pushing for change. Here’s how to get involved:

• Contact your representative: Write to your state and federal legislators, the Honorable Minister of Health, and the NHIS. Share your story and demand action on insulin affordability.
• Join advocacy groups: Organizations like the Diabetes Association of Nigeria and the Nigerian Medical Association welcome volunteers and advocates to amplify patient voices.
• Use social media: Share your experience using the hashtag #InsulinForAll or #EndInsulinCrisis. Tag government officials and health authorities to demand accountability.
• Attend public hearings: The National Assembly often holds sessions on health policy. Participate to ensure patient concerns are heard.
• Support local production: Buy medicines from accredited local manufacturers when available. This sends a signal to the market about demand for affordable, homegrown solutions.

Conclusion: Time for action on insulin price hike

The fivefold increase in insulin prices from ₦5,000 to ₦25,000 is more than a financial crisis—it is a public health emergency. Doctors, patients, and advocates are united in their call for government intervention, but time is running out. Every day without action means more families face impossible choices, more patients skip doses, and more lives are put at risk.

Nigeria has the resources, expertise, and will to solve this crisis. What it needs now is decisive leadership. By regulating prices, subsidizing insulin, and investing in local production, the government can protect millions of Nigerians living with diabetes and set an example for the rest of Africa.

For patients and families, the message is clear: you are not alone. Speak up, seek support, and demand change. The fight for affordable insulin is a fight for life itself.

Take action today

If you or a loved one is affected by the insulin price hike, contact the Diabetes Association of Nigeria at diabetesnigeria.org or call their helpline at 0800-DIABETES. Join a local support group and stay informed about government relief programs.

FAQ: Understanding the insulin price hike in Nigeria

Why has the price of insulin increased so suddenly in Nigeria?

The price increase is driven by global supply chain disruptions, naira depreciation, rising import costs, and middlemen inflating prices. The COVID-19 pandemic worsened existing vulnerabilities in the pharmaceutical supply chain.

What happens if a diabetes patient cannot afford insulin?

Skipping or rationing insulin can lead to severe hyperglycemia, ketoacidosis, organ damage, coma, or death. It is a life-threatening situation that requires immediate medical attention.

Is there any government support available for diabetes patients?

The National Health Insurance Scheme (NHIS) covers some diabetes services, but medication coverage varies. The government is reviewing options to expand subsidies. Patients should check with their local NHIS office or hospital for eligibility.

Can I buy insulin from abroad to save money?

Importing insulin without proper regulation can be risky. Counterfeit or expired insulin may be ineffective or dangerous. Always purchase insulin from licensed pharmacies and consult your doctor before switching brands.

What is being done to produce insulin locally in Nigeria?

The government is offering incentives to pharmaceutical companies to invest in local insulin production. NAFDAC is fast-tracking approvals for new manufacturers. The goal is to reduce import dependency and stabilize prices.

How can I help someone affected by the insulin price hike?

You can support by donating to diabetes charities, advocating for policy change, sharing verified information, or helping patients access support groups and financial aid programs.

Related Reading

• Enugu warns against adulterated oil for okpa cooking
• Nigerian woman opens up on wide pr!vate part after childbirth
• FG to decriminalise suicide attempt, cut cases by 15%